The present application was developed without any government support.
The present invention relates to a hub assembly comprising a connection hub with a self-closing valve. The connection hub may also be attached to a needle or to a catheter. The self-closing valve precludes blood leakage as a syringe barrel is removed from the connection hub and replaced with a second syringe barrel or as an IV unit is coupled to the catheter.
Venipuncture is defined as the puncture of a vein as part of a medical procedure, typically to withdraw a blood sample or for an intravenous injection. Venipuncture may be performed with a needle attached to a syringe or with an over the needle catheter. Intravenous (IV) procedures are commonly used in the medical arts to deliver medications and other fluids to patients.
As is known in the art, a syringe normally comprises a barrel with an end adapted to connect to a needle hub or a connection hub. During a medical procedure, a needle may be attached to a first syringe, the needle is inserted into a patient's vein, and medication within the syringe barrel is injected into the patient. If multiple medications need to be administered, rather than removing the needle the practitioner normally disconnects the first syringe at the connection hub and connects a second syringe to the same connection hub. However, when the first syringe is removed, blood can easily backflow from the punctured vessel through the needle and connection hub, obscuring the work area and putting the practitioner at risk of exposure to blood-borne pathogens.
Typically, an IV procedure is initiated by having a needle encircled by a catheter or plastic sleeve pierce a patient's skin. The needle and catheter are then inserted into a vein or artery to provide the practitioner with access to the circulatory system. The needle is then removed from the catheter, and an IV line is attached to a connection hub. When the needle, which is commonly attached to a syringe, is within the catheter a positive pressure is applied against the blood coursing through the punctured vein or artery so that blood remains in the blood vessel. However, once the needle is removed from the catheter and before the IV line is attached to the connection hub blood can freely flow from the punctured vessel through the catheter. The blood exiting the catheter obscures the working area and exposes the practitioner to direct contact with the patient's blood.
Because intravenous procedures are so common and important in the medical arts, it would be advantageous to have a connection hub designed to keep the blood from exiting through the needle or catheter when the syringe is removed and before the replacement syringe or the IV line is attached. Preferably the design should be relatively simple, thereby reducing the possibility of a failure of the system, and should be capable of being used with the current syringe barrels and IV lines without the need for adapters.
The present development is a connection hub assembly comprising a connection hub with a self-closing valve for use with a syringe barrel. The connection hub is further attached to a needle or catheter, and is adapted to receive a syringe barrel or an IV line. The connection hub assembly includes a self-sealing valve that prevents blood from flowing out of the connection hub assembly as the syringe barrel is removed.
The hub assembly depicted in the various Figures is selected solely for the purposes of illustrating the invention. Other and different hub assemblies may utilize the inventive features described herein as well.
Reference is first made to
The connection hub 20 may be any hub that can reversibly connect with a syringe barrel. The connection hub 20 defines at least three sections-a syringe connection section 22 having a receiver end 24 which is adapted to reversibly receive the syringe barrel 60, a catheter connection section 26 having an entry port 29 and a discharge end 28 which connects to the catheter 40, and a transition section 23 located between the syringe connection section 22 and the catheter connection section 26. The transition section 23 must be large enough to allow a valve flap 34 to open into the transition section 23 without obstructing the entry port 29, as shown in
Exemplary means for reversibly connecting the syringe barrel include, but are not limited to, standard luer-lok fittings or intravenous (IV) tube connection, as are known in the art. The catheter 40 may be fixedly attached to the connection hub 20 or may be reversibly attached using connecting means known in the art, such as standard luer-lok fittings or intravenous (IV) tube connection. In a preferred embodiment, the catheter 40 is fixedly attached to the connection hub 20.
The connection hub 20 can be manufactured from any material which can be produce a semi-rigid device and which can retain the shape of the device during sterilization procedures. Because the practitioner may wish to see blood flowing into and through the connection hub 20, optionally, the connection hub 20 can be manufactured from an essentially translucent material. However, translucency of the material is not required for the connection hub to function as intended.
A bore 25 extends longitudinally through the hub 20 from the receiver end 24 to the entry port 29 and into the discharge end 28. As is known in the art, when the catheter 40 is attached to the discharge end 28, as shown in
The bore 25 defines a first diameter DS in the syringe connection section 22, a second diameter Dr in the transition section 23, and a third diameter DN in the catheter connection section 26. At the point or juncture 27J (not shown) where the syringe connection section 22 meets the transition section 23 the first diameter DS of bore 25 must be larger than the second diameter DT of the bore. In a preferred embodiment, the change from the first diameter DS to the second diameter DT is sharp so that a shelf 27 is created within the bore 25. At the point where the transition section 23 meets the catheter connection section 26 the second diameter DT of bore 25 must be larger than the third diameter DN of the bore, but the narrowing of the bore 25 may be gradual creating a tapered contour. The transition section 23 further defines a length L which is the length from the point where the transition section 23 meets the syringe connection section to the port entry 29.
The self-closing valve 30 is a diaphragm having a slit 32 that transects the diaphragm so that a flap 34 is created that can move when subjected to pressure, such as the movement of fluid through the valve 30. The self-closing valve 30 defines a diaphragm diameter DD which must be slightly smaller than the bore's syringe section diameter DS but larger than the bore's transition section diameter DT. Specifically, the diaphragm diameter DD must be small enough to allow the valve 30 to fit within the bore of the syringe connection section 22 but large enough to fit securely on the shelf 27 to create a barrier between the syringe connection section 22 and the transition section 23. The flap 34 of the valve 30 is created by the slit 32. In a preferred embodiment the slit 32 is an arc with a flap diameter DF and the flap 34 is created by the slit 32 transecting the diaphragm along at least 50% of the arc. In a more preferred embodiment, the slit 32 transects the diaphragm along at least 80% of the arc. To ensure that the flap 34 does not obstruct the entry port 29, the flap 34 is preferably shorter than the transition section length Lt. In a preferred embodiment, the diaphragm is made of self-sealing elastomeric materials so that the flap 34 “closes” when in a resting state, such as but not limited to silicone, polypropylene, polyurethane, styrenic block copolymers, nitriles, fluoroelastomers, perfluoroelasomers, ethylene propylene, ethylene propylene diene monomers, and combinations thereof.
The retaining ring 36 is used to hold the self-closing valve 30 tightly against the shelf 27 and to prevent leakage of fluids from the catheter connection section 26 toward the syringe connection section 22. The retaining ring 36 includes an aperture 37 and a body 35 defined by an outer diameter DRO and an inner diameter DRI. The outer diameter DRO is essentially equal to the bore's transition section diameter DT to ensure that the retaining ring 36 can fit within the bore 25 and will remain secured within the bore 25 by friction. The aperture 37 is defined by the retaining ring's inner diameter DRI. The inner diameter DRI must be smaller than the valve's flap diameter DF so that the flap 34 cannot open into the syringe connection section 22. Rather, when the flap 34 experiences backpressure, such as a flow of fluid moving from the catheter connection section 26 toward the syringe connection section 22 as shown in
The hub assembly 10 of the present invention is prepared by obtaining the connection hub 20 that has the bore 25 and the shelf 27, inserting the self-closing valve 30 into the bore 25 until the valve 30 rests against the shelf 27, and securing the valve 30 against the shelf 27 by inserting the retaining ring 36 into the bore 25. When properly assembled, the retaining ring 36 will remain in position and will hold the valve 30 against the shelf 27 even when the hub assembly 10 is subjected to vibration or jolting.
Except as specifically stated herein, dimensions may vary for all parts of the hub assembly 10. In a first exemplary embodiment, the total length of the hub assembly 10 from the receiver end 24 to the discharge end 28 is about 18.4 mm, the length from the receiver end 24 to the valve 30 is about 5 mm, the inner diameter bore's syringe section diameter DS is about 6 mm, the diaphragm diameter DD is about 6 mm, the flap diameter DF is about 5 mm, the retaining ring outer diameter DRO is about 6 mm, and the retaining ring inner diameter DRI is about 4 mm.
It is anticipated that the hub assembly 10 can be provided to a user in a “ready to use” condition. For example, as shown in
It is anticipated that a first alternative embodiment for the valve 130 may be designed which includes a flap stopper feature, such as shown in
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the presently disclosed subject matter pertains. Representative methods, devices, and materials are described herein, but are not intended to be limiting unless so noted.
The terms “a”, “an”, and “the” refer to “one or more” when used in the subject specification, including the claims.
Unless otherwise indicated, all numbers expressing quantities of components, conditions, and otherwise used in the specification and claims are to be understood as being modified in all instances by the term “about”. Accordingly, unless indicated to the contrary, the numerical parameters set forth in the instant specification and attached claims are approximations that can vary depending upon the desired properties sought to be obtained by the presently disclosed subject matter.
As used herein, the term “about”, when referring to a value or to a measurement or a dimension can encompass variations of, in some embodiments±20%, in some embodiments±10%, in some embodiments±5%, in some embodiments±1%, in some embodiments±0.5%, and in some embodiments to ±0.1%, from the specified value, as such variations are appropriate in the disclosed application.
It is understood that, in light of a reading of the foregoing description, those with ordinary skill in the art will be able to make changes and modifications to the present invention without departing from the spirit or scope of the invention, as defined herein. For example, those skilled in the art may substitute materials supplied by different manufacturers than specified herein without altering the scope of the present invention.
The present application claims priority to U.S. Patent Application No. 63/049,529 filed 8 Jul. 2020, which is incorporated herein in its entirety by reference.
Number | Name | Date | Kind |
---|---|---|---|
4143853 | Abramson | Mar 1979 | A |
4160383 | Rauschenberger | Jul 1979 | A |
4424833 | Spector et al. | Jan 1984 | A |
4430081 | Timmermans | Feb 1984 | A |
4449693 | Gereg | May 1984 | A |
4765588 | Atkinson | Aug 1988 | A |
4842591 | Luther | Jun 1989 | A |
4935010 | Cox et al. | Jun 1990 | A |
5180365 | Ensminger | Jan 1993 | A |
5224938 | Fenton, Jr. | Jul 1993 | A |
5295969 | Fischell | Mar 1994 | A |
5336192 | Palestrant | Aug 1994 | A |
5405323 | Rogers et al. | Apr 1995 | A |
5613663 | Schmidt | Mar 1997 | A |
5858007 | Fagan | Jan 1999 | A |
6066117 | Fox | May 2000 | A |
6533759 | Watson et al. | Mar 2003 | B1 |
6783522 | Fischell | Aug 2004 | B2 |
7331949 | Marisi | Feb 2008 | B2 |
8475434 | Frojd | Jul 2013 | B2 |
8926564 | King | Jan 2015 | B2 |
9408971 | Carlyon | Aug 2016 | B2 |
10596351 | Liska | Mar 2020 | B2 |
20020045863 | Wechler | Apr 2002 | A1 |
20090247986 | Rioux | Oct 2009 | A1 |
20150306349 | Bonnal | Oct 2015 | A1 |
20190298911 | Harward et al. | Oct 2019 | A1 |
20200188634 | Woehr | Jun 2020 | A1 |
Number | Date | Country | |
---|---|---|---|
63049529 | Jul 2020 | US |